MARLBOROUGH, Mass. (AP) _ Boston Scientific Corp. (BSX) on Wednesday reported third-quarter net income of $188 million.
On a per-share basis, the Marlborough, Massachusetts-based company said it had profit of 12 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to 43 cents per share.
The results fell short of Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 44 cents per share.
The medical device manufacturer posted revenue of $3.17 billion in the period, which topped Street forecasts. Ten analysts surveyed by Zacks expected $3.14 billion.
For the current quarter ending in December, Boston Scientific expects its per-share earnings to range from 45 cents to 48 cents.
The company expects full-year earnings in the range of $1.71 to $1.74 per share.
Boston Scientific shares have declined roughly 3% since the beginning of the year, while the S&P's 500 index has decreased 19%. The stock has fallen 7% in the last 12 months.
